n | Female | Male | Age, yr. (mean ± S.E.) | Disease Duration, yr. (mean ± S.E.) | Clinical Scale (mean ± S.E.) | |||||
---|---|---|---|---|---|---|---|---|---|---|
UMSARS | ||||||||||
Part 1 | Part 2 | Part 3 (ΔsBP) | Part 3 (ΔdBP) | Part 4 | ||||||
MSA-C | 31 | 16 (51.6%) | 15 (48.4%) | 60.72 ± 1.73 | 3.09 ± 0.32 | 16.83 ± 1.62 | 15.90 ± 1.69 | −28.93 ± 4.25 | −12.33 ± 2.62 | 2.04 ± 0.20 |
MSA-P | 30 | 17 (56.7%) | 13 (43.3%) | 68.08 ± 1.31 a | 3.01 ± 0.32 | 19.63 ± 1.69 | 22.30 ± 1.85 | −20.56 ± 3.23 | −10.33 ± 2.50 | 2.88 ± 0.19 |
UPDRS | ||||||||||
Part 1 | Part 2 | Part 3 | Part 4 | |||||||
PD | 28 | 15 (53.6%) | 13 (46.4%) | 68.97 ± 1.32 a | 9.58 ± 0.98 b | 2.64 ± 0.42 | 12.78 ± 1.84 | 25.32 ± 3.40 | 2.12 ± 0.51 | |
Control | 28 | 13 (46.4%) | 15 (53.6%) | 63.18 ± 1.29 |